Back
Svenska Handelsbanken AB Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
43
SVNLY
Svenska Handelsbanken AB
Last Price:
$5.70
Seasonality Move:
-5.47%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
43
Svenska Handelsbanken AB (SVNLY)
is a Sell
Is Svenska Handelsbanken AB a Buy, Sell or Hold?
-
The current Svenska Handelsbanken AB [SVNLY] share price is $6.51. The Score for SVNLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SVNLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SVNLY Stock Price Chart
What is Svenska Handelsbanken AB's stock price today?
-
The Svenska Handelsbanken AB share price today is $6.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SVNLY is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
SVNLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 57.22 | Buy |
| Chaikin Money Flow: | 45603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.28 - 6.58) | Buy |
| Bollinger Bands (100): | (5.02 - 6.12) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.53 | Buy |
| Relative Strength Index (14 RSI): | 57.28 | Buy |
| Chaikin Money Flow: | 106003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.42 - 267) | Buy |
| Bollinger Bands (100): | (240.58 - 270.64) | Buy |
SVNLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.52 | Sell |
| 20-day SMA: | 6.48 | Buy |
| 50-day SMA: | 6.01 | Buy |
| 200-day SMA: | 5.24 | Buy |
| 8-day EMA: | 6.51 | Sell |
| 20-day EMA: | 6.42 | Buy |
| 50-day EMA: | 6.09 | Buy |
| 200-day EMA: | 5.43 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 268.31 | Buy |
| 20-day SMA: | 253.84 | Buy |
| 50-day SMA: | 259.68 | Buy |
| 200-day SMA: | 253.36 | Buy |
| 8-day EMA: | 268.69 | Buy |
| 20-day EMA: | 260.57 | Buy |
| 50-day EMA: | 257.45 | Buy |
| 200-day EMA: | 244.33 | Buy |
Svenska Handelsbanken AB Earnings Growth & SVNLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Svenska Handelsbanken AB Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||